Legal & General Group PLC Immunity Bio, Inc. Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
A detailed history of Legal & General Group PLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 142,525 shares of IBRX stock, worth $639,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142,525
Previous 142,525
-0.0%
Holding current value
$639,937
Previous $528,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IBRX
# of Institutions
202Shares Held
70MCall Options Held
1.68MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$75.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$51.3 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$38.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$17.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$10.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.8B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...